Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances

Diabetic nephropathy (DN) is one of the most common kidney diseases, but its exact pathophysiology remains unknown. Toll-like receptors (TLRs) are innate immune receptors that recognize pathogen- and danger-associated molecular patterns, which can result in an inflammatory response. TLR4, TLR2, TLR5...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Sadra Gholami Chahkand, Yasaman Tavakoli, Ava Aghakhani, Monireh Askarzadeh, Hosein Azimi, Nogol Ghalamkarpour, Alaleh Alizadeh, Iman Archin, Sajad Kermani, Akram Ansari, Mohadeseh Poudineh, Zahra Mali, Elaheh Foroughi, Gisou Erabi, Seyed Amirhossein Mazhari, Mohammad Sadegh Fallahi, Niloofar Deravi, Parisa Alsadat Dadkhah
Format: Article
Language:English
Published: Galenos Publishing House 2024-08-01
Series:Turkish Journal of Immunology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tji&un=TJI-26213
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525665685307392
author Mohammad Sadra Gholami Chahkand
Yasaman Tavakoli
Ava Aghakhani
Monireh Askarzadeh
Hosein Azimi
Nogol Ghalamkarpour
Alaleh Alizadeh
Iman Archin
Sajad Kermani
Akram Ansari
Mohadeseh Poudineh
Zahra Mali
Elaheh Foroughi
Gisou Erabi
Seyed Amirhossein Mazhari
Mohammad Sadegh Fallahi
Niloofar Deravi
Parisa Alsadat Dadkhah
author_facet Mohammad Sadra Gholami Chahkand
Yasaman Tavakoli
Ava Aghakhani
Monireh Askarzadeh
Hosein Azimi
Nogol Ghalamkarpour
Alaleh Alizadeh
Iman Archin
Sajad Kermani
Akram Ansari
Mohadeseh Poudineh
Zahra Mali
Elaheh Foroughi
Gisou Erabi
Seyed Amirhossein Mazhari
Mohammad Sadegh Fallahi
Niloofar Deravi
Parisa Alsadat Dadkhah
author_sort Mohammad Sadra Gholami Chahkand
collection DOAJ
description Diabetic nephropathy (DN) is one of the most common kidney diseases, but its exact pathophysiology remains unknown. Toll-like receptors (TLRs) are innate immune receptors that recognize pathogen- and danger-associated molecular patterns, which can result in an inflammatory response. TLR4, TLR2, TLR5, TLR7, TLR8, TLR9, and TLR11 are essential in the pathogenesis of DN, according to recent evidence collected from both in vivo and in vitro studies. Studies have shown that TLR2 and TLR4 expression is higher in patients with renal failure and nephrotic diabetes. They also play critical roles in podocyte injury and inflammation caused by high glucose. TLR2 and TLR4 may be helpful therapeutic targets to prevent or delay DN in patients with type 2 diabetes mellitus. Additionally, TLR7 may contribute to kidney damage in type 1 diabetes mellitus, whereas downregulation of TLR9 expression inhibits inflammation and apoptosis pathways associated with DN.
format Article
id doaj-art-f92748e2676b4b8a89c12935f562e11f
institution Kabale University
issn 1301-109X
2147-8325
language English
publishDate 2024-08-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Immunology
spelling doaj-art-f92748e2676b4b8a89c12935f562e11f2025-01-17T08:19:14ZengGalenos Publishing HouseTurkish Journal of Immunology1301-109X2147-83252024-08-01122355510.4274/tji.galenos.2024.26213TJI-26213Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent AdvancesMohammad Sadra Gholami Chahkand0Yasaman Tavakoli1Ava Aghakhani2Monireh Askarzadeh3Hosein Azimi4Nogol Ghalamkarpour5Alaleh Alizadeh6Iman Archin7Sajad Kermani8Akram Ansari9Mohadeseh Poudineh10Zahra Mali11Elaheh Foroughi12Gisou Erabi13Seyed Amirhossein Mazhari14Mohammad Sadegh Fallahi15Niloofar Deravi16Parisa Alsadat Dadkhah17Golestan University of Medical Sciences, School of Medicine, Student Research Committee, Gorgan, IranMazandaran University of Medical Science, Department of Medicine, Mazandaran, IranTehran University of Medical Sciences, School of Medicine, Tehran, IranMazandaran University of Medical Sciences, School of Medicine, Student Research Committee, Sari, IranIran University of Medical Sciences, School of Medicine, Student Research Committee, Tehran, IranLorestan University of Medical Sciences, School of Allied Medicine, Department of Clinical Laboratory Sciences, Student Research Committee, Khorramabad, IranIslamic Azad University Faculty of Medicine, Student Research Committee, Mashhad Branch, Mashhad, IranKazan (Volga Region) Federal University, Kazan, RussiaIslamic Azad University Faculty of Medicine, Student Research Committee, Mashhad Branch, Mashhad, IranShantou University Medical College, Student Research Committee Shantou, Guangdong, ChinaZanjan University of Medical Sciences, School of Medicine, Zanjan, IranUrmia University of Medical Sciences, School of Medicine, IranIsfahan University of Medical Sciences, School of Medicine, Student Research Committee, Isfahan, IranUrmia University of Medical Sciences, Student Research Committee, Urmia, IranAzerbaijan Medical University, Student Research Committee, Baku, AzerbaijanTehran University of Medical Sciences, School of Medicine, Tehran, IranShahid Beheshti University of Medical Sciences, School of Medicine, Student Research Committee, Arabi Ave, IranIsfahan University of Medical Sciences, School of Medicine, Student Research Committee, Isfahan, IranDiabetic nephropathy (DN) is one of the most common kidney diseases, but its exact pathophysiology remains unknown. Toll-like receptors (TLRs) are innate immune receptors that recognize pathogen- and danger-associated molecular patterns, which can result in an inflammatory response. TLR4, TLR2, TLR5, TLR7, TLR8, TLR9, and TLR11 are essential in the pathogenesis of DN, according to recent evidence collected from both in vivo and in vitro studies. Studies have shown that TLR2 and TLR4 expression is higher in patients with renal failure and nephrotic diabetes. They also play critical roles in podocyte injury and inflammation caused by high glucose. TLR2 and TLR4 may be helpful therapeutic targets to prevent or delay DN in patients with type 2 diabetes mellitus. Additionally, TLR7 may contribute to kidney damage in type 1 diabetes mellitus, whereas downregulation of TLR9 expression inhibits inflammation and apoptosis pathways associated with DN.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tji&un=TJI-26213toll-like receptornephropathydiabetic kidney diseasechronic kidney diseasetlrs
spellingShingle Mohammad Sadra Gholami Chahkand
Yasaman Tavakoli
Ava Aghakhani
Monireh Askarzadeh
Hosein Azimi
Nogol Ghalamkarpour
Alaleh Alizadeh
Iman Archin
Sajad Kermani
Akram Ansari
Mohadeseh Poudineh
Zahra Mali
Elaheh Foroughi
Gisou Erabi
Seyed Amirhossein Mazhari
Mohammad Sadegh Fallahi
Niloofar Deravi
Parisa Alsadat Dadkhah
Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
Turkish Journal of Immunology
toll-like receptor
nephropathy
diabetic kidney disease
chronic kidney disease
tlrs
title Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
title_full Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
title_fullStr Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
title_full_unstemmed Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
title_short Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
title_sort toll like receptors and diabetic nephropathy a review of recent advances
topic toll-like receptor
nephropathy
diabetic kidney disease
chronic kidney disease
tlrs
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tji&un=TJI-26213
work_keys_str_mv AT mohammadsadragholamichahkand tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT yasamantavakoli tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT avaaghakhani tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT monirehaskarzadeh tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT hoseinazimi tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT nogolghalamkarpour tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT alalehalizadeh tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT imanarchin tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT sajadkermani tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT akramansari tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT mohadesehpoudineh tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT zahramali tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT elahehforoughi tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT gisouerabi tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT seyedamirhosseinmazhari tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT mohammadsadeghfallahi tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT niloofarderavi tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances
AT parisaalsadatdadkhah tolllikereceptorsanddiabeticnephropathyareviewofrecentadvances